249 Characterization of unresectable and/or metastatic solid tumors patients treated with systemic anticancer therapy in first-line settings: a pan-tumor community-oncology based study

• Elise Wu,
• Alexander Spira,
• Sneha Sura

Affiliations

Elise Wu

8 Bristol-Myers Squibb, New York, New York, USA

Alexander Spira

Department of Medical Oncology, Virginia Cancer Specialists, Fairfax, Virginia, USA

Sneha Sura

2McKesson Life Sciences, The Woodlands, TX, USA